Coffman, Robert L.
Dynavax Technologies Corporation,
United States
2024 Rank: 52135
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 1051 out of 157372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 52135 | 60497 |
| Total Cites | 1206 | 1251 |
| H-index | 16 | 16 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 3 | 3 |
| Number of Single+First Authored Papers | 34 | 34 |
| Total Cites to Single+First Authored Papers | 159 | 159 |
| Number of Single+First+Last Authored Papers | 119 | 119 |
| Total Cites to Single+First+Last Authored Papers | 405 | 407 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1099 | 1135 |
| Ratio of Total Citations to Distinct Citing Papers | 1.10 | 1.10 |
| Self-Citation Percentage |
3.60%
|
|
Coffman, Robert L.
Dynavax Technologies Corporation,
United States
2023 Rank: 36814
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 839 out of 147556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 36814 | 39880 |
| Total Cites | 1438 | 1502 |
| H-index | 18 | 19 |
| Hm-index | 5 | 6 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 6 | 6 |
| Number of Single+First Authored Papers | 34 | 34 |
| Total Cites to Single+First Authored Papers | 179 | 181 |
| Number of Single+First+Last Authored Papers | 119 | 119 |
| Total Cites to Single+First+Last Authored Papers | 456 | 462 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1276 | 1322 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.14 |
| Self-Citation Percentage |
4.26%
|
|
Coffman, Robert L.
Dynavax Technologies Corporation,
United States
2022 Rank: 23179
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 621 out of 138599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 23179 | 26950 |
| Total Cites | 1587 | 1637 |
| H-index | 19 | 19 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 10 | 10 |
| Number of Single+First Authored Papers | 34 | 34 |
| Total Cites to Single+First Authored Papers | 185 | 187 |
| Number of Single+First+Last Authored Papers | 116 | 116 |
| Total Cites to Single+First+Last Authored Papers | 536 | 542 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1379 | 1415 |
| Ratio of Total Citations to Distinct Citing Papers | 1.15 | 1.16 |
| Self-Citation Percentage |
3.05%
|
|
Coffman, Robert L.
Dynavax Technologies Corporation,
United States
2021 Rank: 25620
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 648 out of 127911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 25620 | 28784 |
| Total Cites | 2194 | 2239 |
| H-index | 21 | 22 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 13 | 13 |
| Number of Single+First Authored Papers | 34 | 34 |
| Total Cites to Single+First Authored Papers | 276 | 278 |
| Number of Single+First+Last Authored Papers | 116 | 116 |
| Total Cites to Single+First+Last Authored Papers | 772 | 779 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1924 | 1956 |
| Ratio of Total Citations to Distinct Citing Papers | 1.14 | 1.14 |
| Self-Citation Percentage |
2.01%
|
|
Coffman, Robert L.
Dynavax Technologies Corporation,
United States
2020 Rank: 35393
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Allergy
Rank in SubField 1: 799 out of 108509 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 35393 | 37884 |
| Total Cites | 1721 | 1792 |
| H-index | 20 | 20 |
| Hm-index | 6 | 7 |
| Number of Single Authored Papers | 9 | 9 |
| Total Cites to Single Authored Papers | 3 | 3 |
| Number of Single+First Authored Papers | 33 | 33 |
| Total Cites to Single+First Authored Papers | 189 | 191 |
| Number of Single+First+Last Authored Papers | 114 | 114 |
| Total Cites to Single+First+Last Authored Papers | 606 | 619 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1533 | 1563 |
| Ratio of Total Citations to Distinct Citing Papers | 1.12 | 1.15 |
| Self-Citation Percentage |
3.96%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.